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Aggressive multimodality treatment of
invasive thymic carcinoma
Michael A. Greene, MD, FCCP, and Mark A. Malias, MD, FCCP,
Melbourne, Fla
Thymic carcinomas are epithelial neoplasms of the thy-mus generally characterized by extensive local invasionand distant metastases. Overall prognosis is poor, with5-year survivals of 31% to 50%.1 Blumberg and asso-
ciates2 found innominate vessel invasion (vein or artery) to be the
only statistically significant predictor of poor survival according to
univariate analysis. We report a case of thymic carcinoma with
extensive local invasion treated with en bloc surgical resection
followed by chemotherapy and radiation.
Clinical Summary
A 48-year-old nonsmoking woman had an approximately 2-year
history of intermittent chest discomfort attributed to costochondri-
tis. After a day of vigorous physical exertion, she had acute
shortness of breath and right-sided chest pain. She was treated with
anti-inflammatory medications. However, a chest radiograph
showed a prominent right hilum. She underwent chest computed
tomographic and magnetic resonance imaging scans, which dem-
onstrated a large (8.5 cm) anterior mediastinal mass (Figures 1 and
2). A biopsy specimen of the mass was obtained through a small
anterior right parasternal incision, and moderately differentiated
squamous cell thymic carcinoma was diagnosed (Figure 3).
The patient’s en bloc surgical resection was extensive because
of direct tumor invasion of the surrounding structures. Obtaining
negative margins required resection of the right anterior chest wall
with partial sternectomy, partial right lung upper lobectomy, and
mediastinal soft tissue resection, including resection of the pleura,
pericardium, and right phrenic nerve. Resection of tumor involve-
ment of the innominate vein and superior vena cava was accom-
plished with systemic heparinization and the placement of a tem-
porary shunt connecting the confluence of the right subclavian and
jugular veins with the right atrium.
The superior vena cava was reconstructed with autologous
pericardium. Transient sinus node dysfunction as a result of clamp
occlusion of the superior vena caval–right atrial junction was
treated during the operation with temporary atrial pacing.
The chest wall soft tissue defect was closed with a pectoralis
rotational flap and local fasciocutaneous flap advancement. The
patient was extubated after 3 days, with minimal paradoxic right
chest wall excursion noted. An elevated right diaphragm as a result
of phrenic nerve resection was observed, as expected, on the
postoperative chest radiograph.
Oral anticoagulation therapy was started to prevent thrombosis
of the extensive pericardial reconstruction of the innominate and
superior caval veins. The patient was discharged after 11 days and
later returned for outpatient placement of a femoral vein chemo-
therapy infusion port.
Subsequent treatment included chemotherapy consisting of 6
cycles of paclitaxel at 150 mg/m2 (255 mg) with 6 cycles of
carboplatin (540 mg each dose), followed by radiation therapy
(Table 1). Preoperative induction radiation of the tumor was
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considered. However, concerns that the radiation would limit
the surgeon’s ability to determine tumor margins weighed on
the decision to resect first and then apply postoperative radia-
tion.
During follow-up, the patient had 2 episodes of swollen left
upper extremity as a result of left subclavian venous obstruction;
both episodes were treated with warfarin sodium with resolution of
swelling. A computed tomographic scan performed 28 months
after the operation showed no evidence of tumor recurrence (Fig-
ure 4). This disease-free interval is encouraging. However, the
patient still requires close follow-up, because late recurrences are
common with this tumor type.
Figure 1. Preoperative radiographic tumor appearance.
Figure 2. Preoperative radiographic tumor appearance.
Figure 3. Photomicrograph of resected thymic carcinoma.
Figure 4. Postoperative scan of chest resection site without
recurrence.
TABLE 1. Postoperative radiation treatment plan for thymic carcinoma
Anatomic treatment site Technique Source
Daily dose
(Gy)
Total
treatments
Elapsed time
(d)
Site dose
(Gy)
Anterior mediastinum,
bilateral subclavian
Anteroposterior,
posteroanterior
6/15x 1.2* 36 43.2
Cone down anterior
mediastinum
Anteroposterior mixed
beam
6x/18e 1.2* 6 7.2
Cone down No. 2
anterior mediastinum
Right anterior oblique,
left anterior oblique
6x 1.2* 8 9.6
Anterior mediastinum
total
50 36 60
*Total dose, administered in 2 divided doses.
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Discussion
Thymic carcinomas comprise only 0.06% of thymic neoplasms.
The rarity of these tumors and differences in classification systems
combine to make analysis of treatment outcomes problematic.
Various treatment combinations with chemotherapy, radiation
therapy, and surgery have been used to treat advanced lesions.3
Radical resections combined with chemotherapy and radiation,
such as this case report, have been reported with favorable disease-
free survival.4 Other authors have also noted favorable trends
among patients treated with postoperative radiation.5 Further clin-
ical experience with aggressive multimodality therapy will be
necessary to establish optimal protocols for the treatment of these
tumors.
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